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Adeno-associated virus (AAV) replication is dependent on two copies of a 145-bp inverted terminal repeat
(ITR) that flank the AAV genome. This is the primary cis-acting element required for productive infection and
the generation of recombinant AAV (rAAV) vectors. We have engineered a plasmid (pDD-2) containing only
165 bp of AAV sequence: two copies of the D element, a unique sequence adjacent to the AAV nicking site,
flanking a single ITR. When assayed in vivo, this modified hairpin was sufficient for the replication of the
plasmid vector when Rep and adenovirus (Ad) helper functions were supplied in trans. pDD-2 replication
intermediates were characteristic of the AAV replication scheme in which linear monomer, dimer, and other
higher-molecular-weight replicative intermediates are generated. Compared to infectious AAV clones for
replication, the modified hairpin vector replicated more efficiently independent of size. Further analysis
demonstrated conversion of the input circular plasmid to a linear substrate with AAV terminal repeat elements
at either end as an initial step for replication. This conversion was independent of both Rep and Ad helper
genes, suggesting the role of host factors in the production of these molecules. The generation of these
substrates suggested resolution of the modified terminal repeat through a Holliday-like structure rather than
replication as a mechanism for rescue. Production of replicative intermediates via this plasmid substrate were
competent not only for AAV DNA replication but also for encapsidation, infection, integration, and subsequent
rescue from the chromosome when superinfected with Ad and wild-type AAV. These studies demonstrate that
this novel 165-bp ITR substrate is sufficient in cis for the AAV life cycle and should provide a valuable reagent
for further dissecting the cis sequences involved in AAV replication, packaging, and integration. In addition,
this novel plasmid vector can be used as a substrate for both rAAV vector production and synthetic plasmid
vector delivery.
Adeno-associated virus (AAV) is a nonpathogenic defective
parvovirus which contains a single-stranded DNA genome of
4,680 nucleotides. The defective nature of the virus is charac-
terized by its dependence on a helper virus, e.g., adenovirus
(Ad) or herpes simplex virus, for lytic infection and production
of progeny. In the absence of the helper virus, AAV establishes
a latent infection by integrating into the host genome. Cells
that have been latently infected with AAV can reenter the lytic
pathway after superinfection with a helper virus (for reviews,
see references 1, 2, and 22).
Genetic analysis of the AAV genome has identified three
major components: the two trans-acting Rep and Cap genes
that are required for viral DNA replication and virion produc-
tion; and cis-acting inverted terminal repeats (ITRs) required
for replication, packaging, integration, and rescue of the AAV
genome (1, 22, 29). The ITR is a 145-bp element in which the
first 125 nucleotides contain palindromic sequence elements in
the order A, B, B9, C, C9 A9 (see Fig. 2). These sequences are
over 80% GC rich and are capable of forming a T-shaped
secondary structure when the viral genome is in a single-
stranded form (Fig. 1 and 2). After infection, the 39 end of the
T-shaped ITR serves as a primer for DNA replication, con-
verting the single-stranded genome into a double-stranded
template with a covalently closed hairpin at one end (Fig. 1A,
construct a). Between the palindromic A sequence and unique
D sequence of the terminal repeat (TR) resides the terminal
resolution site (trs) recognized by the Rep proteins (Fig. 1A,
construct b). Completion of the replication scheme requires
resolution of the covalently closed hairpin structure by Rep-
dependent nicking, which results in the transfer of this se-
quence to the progeny DNA. The nicking reaction generates a
new 39 OH on the parental strand, providing the substrate for
copying back the transferred ITR sequences (13, 15 for a
review, see reference 22).
In the presence of helper viruses or when infected cells are
stressed by genotoxic treatment (44–46), AAV will enter the
replication cycle via the terminal transfer model (3, 22). Dur-
ing AAV replication, DNA intermediates containing head-to-
head and tail-to-tail dimeric molecules are generated from
reinitiation of replication on monomer substrates (Fig. 1A,
construct c) (12, 36). These intermediates are novel in that a
single ITR flanked by unique D and D9 sequences forms a
bridge between the two AAV molecules (Fig. 1A, construct d).
Resolution of these molecules back to the monomer pool en-
sures the production of wild-type virus. Similar dimer interme-
diates have been found in AAV proviral structures, suggesting
the importance of this structure in the AAV life cycle (Fig. 1).
These results suggest that our understanding of these critical
sequences is still incomplete, although a model relying on the
dimer intermediates has been proposed for successful rescue
from the integrated state (25).
Previous studies have demonstrated that both ITRs seem to
be required for AAV viability. Infectious clones containing the
AAV genome, when transfected into Ad-infected cells, will
rescue from the plasmid backbone and replicate to produce
wild-type AAV virions (29, 32). Furthermore, if the AAV cod-
ing region is replaced by foreign DNA, these recombinant
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AAV plasmids can still rescue and replicate, as long as the two
ITRs are present in cis and the Rep and Cap gene products are
supplied in trans (9, 27, 37). However, when one of the two
ITRs is completely deleted or partially deleted in such a man-
ner that it cannot be repaired by gene conversion, the substrate
is not viable for virus production (29, 32). Recently, a report
has demonstrated that a cryptic trs in the AAV p5 promoter
can partially substitute for replication if the left end ITR is
completely deleted (39, 40).
Efforts to further delineate the cis-acting DNA sequences
necessary for AAV viability have determined that the 20-bp D
sequence of the ITR plays a critical role in viral DNA rescue
and replication. Deletion of the D sequence from both ITRs
severely impairs AAV DNA replication (39, 40, 43). Further-
more, when infectious wild-type AAV plasmids are transfected
into Ad-infected cells, only the AAV portion which contains
the ITR and D sequence of the plasmid is capable of replica-
tion after rescue. This same phenomenon was also found in an
in vitro rescue and replication experiment (11). According to
the AAV rescue model (41), two linear DNA fragments con-
sisting of AAV and plasmid backbone are generated from the
infectious clone by excision through the ITRs (Fig. 1B). Both
FIG. 1. (A) Generation of DD ITR intermediates in the AAV life cycle. Lytic
constructs: a, single-stranded AAV molecule with TRs in the hairpin conforma-
tion; b, product generated after the first round of replication (small arrows
denote the AAV nicking site positioned between the A and D palindromes); c,
reinitiation of replication off of a linear duplex substrate; d, dimer replicative
intermediate (the boxed portion illustrates DD ITR intermediate generated
during AAV replication). Latent, diagram illustrating the same DD ITR inter-
mediate (boxed) as it exists in proviral state. Wavy lines represent chromosomal
DNA. (B) Model for AAV rescue. Plasmid pSM620 is a wild-type infectious
AAV construct containing the entire AAV-2 genome (top half of the plasmid)
including two ITRs with only one copy of the D elements (denoted by the
cruciform structures and the black box labeled D within the circular construct).
Plasmid pDD-2 contains only one modified ITR sequence (drawn as a cruciform
structure flanked by two copies of the D element). The ITRs in the plasmids are
drawn to show the cruciform structure that they can form due to palindromic
sequences within the ITRs. Diagonal arrows show potential sites of resolution.
Linear molecules with covalently closed T-shaped ITRs at the termini are the
products of resolution. Note that the resolved linear AAV and pDD-2 molecules
contain covalently closed ITRs with D sequences, in contrast to the linear
plasmid portion from pSM620, which contains only convalently closed ITRs.
FIG. 2. Construction of plasmid pDD-2. a, diagram showing the 39 hairpin
structure formed after heat denaturation of linear AAV virus (A, A9, B, B9, C,
C9, and D represent palindromic sequences within the ITR). b, Product gener-
ated after the first round of PCR in the absence of primer. Note that this step
relies on the self-priming mechanism of the AAV ITRs. c, Template used for
primer-specific PCR (primer denoted by the horizontal arrow). Note that after
the first round of PCR, the template primer contains two copies of the D element
flanking the ITR palindromic sequences. d, Final product generated from single-
primer PCR. e, Cloning of the modified DD ITR via EcoRI restriction sites into
a pGEM-3Z plasmid vector.
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linear molecules generated contain covalently closed T-shaped
ITR structures on each end. However, only the AAV mole-
cules containing D or D9 sequences, preserving the trs, go on to
replicate (Fig. 1B). AAV vectors are identical to wild-type
clones in that after rescue, only vector sequences flanked by
ITRs with D elements go on to replicate (26, 29). From these
data, we hypothesized that any plasmid substrate containing a
single modified ITR flanked by D and D9 sequences should
rescue (Fig. 1B) and replicate via the AAV replication scheme.
To test this hypothesis and better elucidate the role of the D
sequence, we have constructed a novel modified TR structure
by using PCR (Fig. 2). This 165-bp ITR has flanking D and D9
sequences which when transfected in cis into Rep-expressing
human cells confers rescue and replication to plasmid sub-
strates regardless of size. Replication intermediates generated
with this substrate (monomer, dimer, etc.) are produced via the
AAV replication scheme and appear to be very efficient com-
pared to infectious clones containing two wild-type ITRs. Res-
cue experiments suggest that resolution occurs through the
modified ITR via a Holliday-like structure, generating linear
molecules with covalently closed hairpins at either end. Inter-
estingly, this resolution process can take place in the absence
of both Ad and AAV gene expression, suggesting a role for
host functions in this initial step. Replicating molecules gen-
erated from this ITR substrate are capable of completing the
entire AAV life cycle, including packaging, infection, integra-
tion, and subsequent rescue after helper and wild-type super-
infection. These studies have determined that this modified
ITR is sufficient in cis for all steps of the AAV life cycle and
should be an important substrate for further characterization
of cis elements required for AAV replication, packaging, and
integration. In addition, this novel ITR provides a unique sub-
strate for the study of synthetic AAV plasmid vectors in vivo.
MATERIALS AND METHODS
Cell lines and general procedures. Human Detroit 6 and 293 cells were
maintained in Dulbecco’s modified Eagle medium (DMEM; GIBCO-BRL) sup-
plemented with 10% fetal calf serum (FCS; HyClone) at 378C in CO2-controlled
environments. Low-molecular-weight DNA from transfected cells was extracted
as described by Hirt (10). Any general molecular biological techniques used in
this study were performed according to standard procedures described previously
(24) unless otherwise noted.
DNA transfection and construction of rAAV stocks. Transfection of plasmid
DNA was performed by using Lipofectin as described by the manufacturer
(GIBCO-BRL). Subconfluent 293 cells in a 6-cm-diameter dish were washed
twice with DMEM. Five micrograms of plasmid DNA was incubated with 50 ml
of Lipofectin at room temperature for 10 min, mixed with 2 ml of Opti-MEM
(GIBCO), and added to the cells. After 12 h, the medium was replaced with 3 ml
of fresh DMEM containing 10% FCS with or without Ad type 5 (Ad5) at a
multiplicity of infection of 5. The cells were incubated for an additional 48 h. To
produce recombinant AAV (rAAV), the vector plasmid and the helper plasmid
pAAV/Ad (27) (in a 1:3 ratio) were cotransfected into the cells as described
above. At 48 h after Ad5 infection, the cells were harvested and resuspended in
1 ml of Opti-MEM. After three freeze-thaw cycles, the cellular debris was
removed by low-speed centrifugation. The virus lysate was heated at 568C for 30
min to inactivate Ad and then stored at 2208C.
Southern hybridization. Restriction enzyme-digested DNA subject to South-
ern analysis was separated on agarose gels and then transferred onto Genescreen
Plus nylon membranes (Du Pont). Southern hybridizations using [a-32P]dCTP
random primer-labeled plasmids were performed as recommended by the man-
ufacturer (Du Pont). Southern hybridizations using [g-32P]ATP-end-labeled ITR
oligonucleotide probe A-1 (59TTGGCCACTCCCTCTCTGCG39, derived from
the A region of the ITR) were carried out as follows. DNA-bound nylon mem-
branes were prehybridized in 53 SSC (13 SSC is 0.15 M NaCl plus 0.15 M
sodium citrate)–103 Denhardt’s solution–10% dextran sulfate–5% sodium do-
decyl sulfate at 608C for at least 1 h. Twenty-five nanograms of 32P-end-labeled
probe and 200 mg of heat-denatured salmon sperm DNA in 0.5 ml of H2O were
then added, and hybridization was carried out at 608C overnight. The membranes
were then washed twice in 33 SSC–5% sodium dodecyl sulfate at 608C for 30 min
and once in 0.23 SSC at room temperature for 10 min. Probe hybridization was
visualized by exposure of hybridized membranes to X-ray film (Du Pont).
PCR and construction of ITR plasmids. Low-molecular-weight DNA from
AAV/Ad5-infected cells was used as the template for the generation of the
double-D (DD) TR, using a single primer (TR-1) derived from the D sequence
of AAV. PCRs were performed at 958C for 1 min, 558C for 30 s, and 728C for 1
min for 35 cycles in a 50-ml volume containing 20 mM Tris-HCl (pH 8.8), 1.5 mM
MgCl2, 50 mM KCl, 2.5% formamide, 100 mM dATP, dTTP, and dCTP, 75 mM
7-deaza-dGTP, 25 mM dGTP, 2.5 U of AmpliTaq (Perkin-Elmer Cetus), 1 ng of
AAV DNA, and 100 pmol of primer TR-1 (59GGAATTCAGGAACCCCTAG
TGATGG39). The PCR product was isolated by agarose gel electrophoresis, cut
with EcoRI, and ligated with an EcoRI-digested and dephosphorylated plasmid,
pGEM-3Z (Promega). The ligated plasmid was transformed into Escherichia coli
Sure cells (Stratagene). Positive clones were screened for the presence of the DD
TR by colony hybridization and confirmed by dideoxy sequencing with 7-deaza-
dGTP substituted for dGTP (31). The selected DD clone was named pDD-2.
Plasmid pDD-neo was constructed by using a neo gene cassette excised with XhoI
and SalI from plasmid pMC1-neo polyA (Stratagene) and cloned into the SalI
site of pDD-2. Plasmid pDD-AAV was constructed by inserting the 4.3-kb XbaI
fragment from psub201 (28) into the XbaI site of pDD-2.
Cloning of Neor cell lines. AAV stocks prepared from pDD-neo as described
above were used to infect (multiplicity of infection of 10) 80% confluent Detroit
6 cells maintained in DMEM with 10% FCS plus antibiotics. At 24 h postinfec-
tion, neomycin-resistant (Neor) cells were selected in the presence of geneticin
G418 (GIBCO) at 400 mg/ml. Single cell clones were isolated and expanded
under G418 selection.
RESULTS
Construction of a modified AAV ITR with DD sequences.
PCR was used to create the ITR with flanking D elements (Fig.
2). The rationale is based on the T-shaped structure of the
AAV ITR. Upon denaturation, this single-stranded DNA can
serve as a template for self-primed PCR based on the inverted
symmetry of the A-A9, B-B9, C-C9, D sequences in the ITR
(Fig. 2, construct a). Viral DNA was isolated, denatured to
promote self-priming hairpin structures, and extended with
Taq polymerase in the first round of the PCR without the
addition of primers. The self-primed elongated material will
produce a T-shaped hairpin structure containing flanking D
and D9 sequences (Fig. 2, construct b). Following elongation, a
single primer homologous to the D sequence with EcoRI
adapter sequences was used (Fig. 2, construct c) to amplify the
desired hairpin product (Fig. 2, construct d). Due to the high
GC content and the strong palindromic structure in the ITR
region, incorporation of 7-deaza-dGTP, 2.5% formamide, and
a high concentration of primer were used (see Materials and
Methods). PCR product generated from these conditions was
cleaved by EcoRI and cloned into the polylinker of pGEM-3Z
(Fig. 2, construct e). To avoid rearrangement and instability of
the ITR in bacteria, the recombinant plasmid was transformed
into the E. coli recombination-deficient SURE strain (Strat-
agene). Using the strategy described above, we obtained pos-
itive clones, which were confirmed by restriction digestion and
sequencing (data not shown). While many clones lost either
the A or the A9 element during the PCR, two clones contained
an intact ITR consisting of D9A B B9C C9A9D regions at the
EcoRI site of the pGEM-3Z. One plasmid, pDD-2 (Fig. 2,
construct e), was used in in vivo transfection experiments and
assayed for AAV replication.
The DD ITR is sufficient for AAV replication and dependent
on Rep in trans. To determine if the DD ITR was sufficient for
AAV-like replication, plasmid pDD-2 was transfected into
Ad5-infected 293 cells with or without cotransfection of an
AAV helper plasmid, pAAV/Ad (27). The AAV helper plas-
mid pAAV/Ad supplies Rep and Cap proteins in trans but is
incapable of replicating itself due to the absence of AAV ITRs
(27). Low-molecular-weight DNA was isolated 48 h posttrans-
fection and fractionated by electrophoresis on an agarose gel
with or without DpnI digestion followed by Southern blot anal-
ysis (Fig. 3).DpnI distinguishes between newly replicated DNA
and input plasmid DNA based on resistance to digestion due to
loss of methylation. In the absence of the AAV helper plasmid
(Fig. 3, lanes 1 and 2), pDD-2 DNA was completely DpnI
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sensitive (Fig. 3, lane 2). A signal migrating with linear mono-
mer appeared at higher levels than normal in the helper-minus,
DpnI-minus lane (Fig. 3, lane 1), suggesting resolution of the
plasmid (Fig. 1, construct b). Detailed analysis of this linear
DpnI-sensitive product is presented below in Fig. 5. However,
in the presence of helper plasmid (Fig. 3, lanes 3 and 4),
pDD-2 replicated very efficiently and exhibited a typical AAV
replication pattern of monomer, dimer, and other replicated
intermediates (Fig. 3, lanes 3 and 4). All of the replication
intermediates were resistant to DpnI digestion (Fig. 3, lane 4),
supporting the role of this cis element in replication. The
cloning vector pGEM-3Z did not replicate under the same
conditions, and a plasmid containing only the Rep genes was
positive for complementing pDD-2 replication (data not
shown). These experiments demonstrate that pDD-2 replica-
tion is dependent on two factors: the DD ITR in cis and AAV
Rep gene products in trans.
DD ITR replication is efficient and independent of plasmid
size. Since the replication of pDD-2 with one modified ITR
appeared very efficient, a comparison was made between
pDD-2 and two infectious AAV plasmids, psub201 (28) and
pSM620 (26). These constructs contain two ITRs as well as
Rep and Cap genes. Plasmid pDD-2 was cotransfected into
Ad5-infected cells with equal amounts of either pAAV/Ad
helper or infectious clones psub201 and pSM620 DNA. Low-
molecular-weight DNA was isolated digested with DpnI and
analyzed as described above. In this experiment, a labeled
oligonucleotide probe derived from the A region of the ITR
was used to detect all replicated DNAs containing AAV cis-
acting sequences. As illustrated in Fig. 4A, all three plasmids
containing AAV coding genes complemented pDD-2 for rep-
lication. In addition, infectious clone pSM620 replicated to a
level similar to that of pDD-2 (26), while infectious clone
psub201 replicated at a much lower level (Fig. 4A, lanes 4 and
3, respectively). Although psub201 replicated less efficiently, it
complemented pDD-2 replication as effectively as the other
AAV helper constructs (Fig. 4A; compare lane 3 with lanes 2
and 4). Inefficient replication of psub201 is attributed to the
13-bp deletion in the A region of these ITRs, resulting in
impaired rescue and much delayed replication (28). From this
analysis, pDD-2 appeared to replicate as efficiently as if not
better than the infectious clones containing two wild-type
AAV ITRs.
To determine whether the efficient replication of pDD-2
observed above was due to the modified DD ITR or simply due
to the smaller size of the plasmid (2.9 kb), an 1.2-kb Neor gene
fragment was inserted into the SalI site of pDD-2 polylinker.
The new plasmid, pDD-neo, is 4.1 kb in size, similar to wild-
type AAV (4.6 kb). In addition, another variant pDD-2 was
made by inserting the 4.3-kb AAV XbaI fragment from
psub201 into the XbaI site of pDD-2, generating a 7.3-kb
plasmid called pDD-AAV. As shown in Fig. 4B, the three DD
constructs replicated to similar levels regardless of size. These
results demonstrate that the 163-bp modified DD ITR is an
efficient cis-acting substrate for Rep-dependent replication,
and these plasmid substrates are not size dependent.
Rescue involves resolution of the ITR. The ITRs are the
AAV rescue substrates and replication origins (39–41). Since
the DD plasmids contain only a single modified ITR and rep-
licated via an AAV mechanism in the presence of Rep pro-
teins, we tested this substrate for the ability to rescue in vivo.
Previous studies using a plasmid substrate with a deleted ITR
(psub201) demonstrated that the rescue event was a rate-lim-
iting step in viral replication (28). Digestion of a restriction site
engineered to release the plasmid backbone from the viral
sequences of psub201 prior to transfection into Ad-infected
293 cells demonstrated a 10-fold increase in replicating AAV
molecules. Data supporting rescue have been extended by in
vitro studies using wild-type infectious clones (41). Based on
the above studies, and the appearance of a putative rescue
fragment in Fig. 3, lane 1, pDD-2 DNA was assayed for rescue
by transfection into uninfected and Ad5-infected 293 cells (Fig.
5B, lanes 3 and 6 and lanes 1, 2, 4, and 5, respectively), with
and without cotransfection of AAV helper plasmid (Fig. 5B,
lanes 1 and 4 and lanes 2, 3, 5, and 6, respectively). Resolution
of pDD-2 should result in a linear molecule with ITR se-
quences at both ends as diagrammed in Fig. 1B. To distinguish
between input and resolved molecules, low-molecular-weight
DNA was recovered 24 h posttransfection and subjected to
restriction analysis by single-cut enzymes SspI and ScaI, re-
spectively (Fig. 5A). pDD-2 sequences were detected after
Southern blot analysis using an ITR-specific probe. The results
from this analysis are shown in Fig. 5B. After SspI or ScaI
FIG. 3. Replication assay for the plasmid containing the DD ITR. Plasmid
pDD-2 was transfected into Ad5-infected 293 cells with (1) or without (2)
cotransfection of the helper plasmid pAAV/Ad. Low-molecular-weight DNA
was extracted 48 h postinfection and separated on an 1% agarose gel with (1) or
without (2) DpnI digestion. Southern blot hybridization used 32P-labeled plas-
mid pGEM-3Z as a probe. Positions of replicated intermediates are denoted by
monomer and dimer.
FIG. 4. (A) Comparison of replication of pDD-2 with psub201 and pSM620.
Plasmid pDD-2 was transfected alone (lane 1) or cotransfected with an equal
amount of either pAAV/Ad (lane 2), psub201 (lane 3), or pSM620 (lane 4) into
Ad5-infected 293 cells. Low-molecular-weight DNA was extracted, digested with
DpnI and analyzed on an 1% agarose gel by Southern blot hybridization using a
32P-labeled ITR oligonucleotide probe. Monomer and dimer represent the rep-
licated pDD-2 molecules. The arrow indicates the position of the monomer band
expected for wild-type (wt) AAV. (B) Replication assay for DD plasmids of
different sizes. pDD-2, pDD-neo, or pDD-AAV was cotransfected into Ad5-
infected 293 cells with (lanes 1 and 2) or without (lane 3) helper plasmid
pAAV/Ad. Low-molecular-weight DNA was extracted and digested with DpnI
and analyzed on an 1% agarose gel by Southern blot hybridization using a
32P-labeled plasmid pGEM-3Z probe. The molecular weight markers indicate
the position of monomer pDD-2 (2.9 kb), pDD-neo (4.1 kb), and pDD-AAV (7.2
kb).
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digestion, a 2.9-kb unit-length band can be observed in all lanes
migrating with predigested plasmid control (Fig. 5B). This
fragment is generated after SspI or ScaI digestion, which will
linearize unresolved input circular plasmid DNA. Plasmid
DNA resolved in vivo would generate two fragments smaller
than linearized input after restriction digestion (Fig. 5A). Re-
solved products of predicted sizes were observed under all
conditions (Fig. 5B). Use of the ITR-specific probe supported
TR sequences at both ends of the resolved molecules. Al-
though resolution appeared more efficient when AAV and Ad
genes were present (compare lanes 1 and 4 to lanes 2, 3, 5, and
6), Ad alone did not augment resolution (Fig. 5B; compare
lanes 2 and 5 to lanes 3 and 6). In fact, resolution of the
plasmid substrate occurred in noninfected cells, suggesting a
role for host factors in the rescue step (Fig. 5B, lanes 3 and 6).
The additional bands observed in the Ad5-plus-AAV helper
plasmid lanes (Fig. 5B, lanes 1 and 4) are expected products
generated from AAV replicated intermediates as shown in Fig.
5A. The two darker bands in lanes 1 and 4, which are common
fragment in all lanes containing resolved species, are generated
by the digestion of linear monomer and dimer AAV molecules
(Fig. 5B, solid arrowheads), while the two lighter bands rep-
resent products from internal head-to-head or tail-to-tail
dimer junction fragments (Fig. 5B, lanes 1 and 4, open arrow-
heads). Fine restriction mapping confirmed the presence of
ITR sequences at either end of the resolved molecules (data
not shown). The results from this experiment support rescue of
the input circular plasmid to a linear molecule with ITR se-
quences at either end. Resolution of the DD plasmid in the
absence of AAV gene products is in agreement with in vitro
rescue results (41). Based on the previous experiment (Fig. 3),
the rescued DNA molecules were DpnI sensitive and did not
replicate in the absence of Rep (Fig. 3, lanes 2 and 4). These
results in combination with those of Fig. 5 support rescue using
host factors by resolution via the ITR which is independent of
DNA replication.
The DD ITR in cis is sufficient for the complete AAV life
cycle. Since plasmids with the modified DD ITR could effi-
ciently replicate in the AAV replication scheme, we addressed
the remaining steps of the AAV life cycle, primarily packaging,
infection, integration, and rescue after Ad and wild-type AAV
superinfection. First, we assayed if plasmid pDD-neo could be
efficiently packaged into the AAV particles compared with
rAAV-neo plasmid pTR-UF2, derived from wild-type infec-
tious clone pSM620. pTR-UF2 contains an identical thymidine
kinase-neo gene cassette along with a green fluorescent protein
gene flanked by two ITRs (50). The two vector plasmids pDD-
neo and pTR-UF2 should produce virus particles similar in
size (4.1 and 4.3 kb, respectively). The two constructs gener-
ated very similar titers (2.3 3 1010 pDD-neo and 4.0 3 1010
pTR-UF2 particles) when assayed by the viral DNA dot blot
method using a neo-specific probe (data not shown). pDD-neo
virus produced was assayed for transduction and integration.
Infection of human Detroit 6 cells with the DD viral stock
resulted in numerous Neor clones which were isolated for
further characterization. Genomic DNA from a subset of the
clones was analyzed by Southern blot hybridization after sin-
gle-cut restriction enzyme digestion (Fig. 6). Analysis of the
digestion pattern supported independent integration in each
FIG. 5. Restriction analysis of rescue and replicated pDD-2. (A) Schematic
diagram of pDD-2 plasmid replication after resolution showing the monomer
molecule generated after rescue (linear diagram with covalently closed hairpins)
and reinitiation of replication from linear substrates (represented by the double
hairpin structure) to dimer molecules (indicated by linear molecules with co-
valently closed hairpins on either end and a cruciform hairpin structure in the
middle of the dimer molecule). Positions of SspI and ScaI restriction sites for
each substrate are indicated, illustrating the terminal and internal fragments
generated after digestion. (B) Southern blot analysis of pDD-2 rescue and rep-
lication. Plasmid pDD-2 was transfected into Ad5-infected or uninfected 293
cells with (1) or without (2) cotransfection of helper plasmid pAAV/Ad. Low-
molecular-weight DNA was isolated and digested with either SspI or ScaI and
separated on a 1% agarose gel. Southern blot hybridization was performed with
32P-labeled ITR as a probe. The unresolved plasmid DNA is identified as a linear
fragment generated after restriction enzyme digestion and is marked by a large
arrow. The left and right terminal fragments from resolved monomer and dimer
molecules are identified by the solid arrowheads. The head-to-head and tail-to-
tail dimer junction fragments generated after digestion are indicated by the open
arrowheads. Lane p, digested plasmid control.
VOL. 71, 1997 NOVEL AAV TERMINAL REPEAT 945
clone (Fig. 6). Chromosome 19 PCR supported lack of tar-
geted integration (data not shown) consistent with previously
reported AAV vector integration studies. By these criteria,
virus generated by using pDD-2 as a starting substrate was
indistinguishable from that produced from conventional vec-
tors (27, 38) for both virus transduction and integration. We
assayed for rescue and replication of pDD-2 by superinfection
with wild-type AAV-2 and Ad5. After superinfection, low-
molecular-weight DNA was extracted, fractionated on an aga-
rose gel, and probed with a neo-specific fragment for rescued
and replicated vector DNA. In this assay, 6 of 22 Neor cell
clones tested rescued (Fig. 7). These results demonstrate that
the 165-bp DD ITR cis sequence is a sufficient substrate after
resolution for all steps of the AAV life cycle, including DNA
replication, virus encapsidation, integration, and rescue.
DISCUSSION
We have constructed and cloned a novel modified AAV ITR
of 165 bp containing flanking D and D9 sequences. The single
DD ITR is a very effective AAV replication substrate in cis
when Rep is provided in trans. Analysis of the potential sec-
ondary structure formed by this modified ITR suggest why this
substrate may work for both plasmid rescue and replication. In
the unresolved circular plasmid, the DD ITR is an exact replica
of an AAV dimer junction generated during viral DNA repli-
cation (Fig. 1A) (12, 36). These intermediates are naturally
resolved from dimers to monomers as part of the AAV repli-
cation scheme (Fig. 1). The availability of these substrates
immediately after transfection may facilitate their resolution
into Rep-dependent linear replication substrates (see below).
In addition, in a supercoiled plasmid substrate, this modified
ITR sequence has the potential to form a T-shaped hairpin
structure with contiguous D-A elements, the natural substrate
for binding and nicking of AAV Rep proteins (Fig. 1B) (13, 14,
23, 33). This contiguous D-A stem structure, which is present
in the hairpin structure of AAV replication monomer inter-
mediates, as well as the resolved plasmid product described
above (Fig. 1B), may enter the AAV replication scheme more
efficiently (12, 36). Therefore, it appears that this cis element
that we constructed may generate AAV replication substrates
by two mechanisms: resolution and Rep-dependent nicking.
Resolution of DD plasmid. Our rescue assay determined
that the input circular plasmid was converted to a linear mol-
ecule with covalently closed hairpin ITR structures at either
end (Fig. 5). This product is identical to the no-end substrate
synthesized in vitro and used in AAV Rep nicking assays (35)
as well as the type of molecule generated in an in vitro rescue
experiment previously described (41). From our analysis, it
appears that resolution takes place through a Holliday-like
structure which can form due to the secondary structure of the
ITR sequences, which is replication independent (Fig. 1B, 3,
and 5). While this is an intriguing observation, more important
is the fact that resolution could take place in noninfected cells,
suggesting a role for host enzymes. The fact that the DD
plasmid can be resolved in noninfected cells, and the fact that
numerous latently AAV-infected cell lines contain provirus in
the form of dimers (see Fig. 1) or multimers (4, 19, 21, 25)
carrying DD-like ITR structures between adjacent AAV mol-
ecules, is very interesting (6, 49). Previous studies have indi-
cated that AAV can rescue from integrated proviral structures
in the absence of Ad superinfection (21). In addition, none of
the virus-cell junctions isolated to date contain intact ITRs (16,
30, 42). These two observations suggest that assurance of res-
cue from the proviral state requires preservation of at least one
intact ITR sequence after integration. Dimer integrants con-
taining DD ITR sequences as diagrammed in Fig. 1 achieve
this objective. This structure not only provides a means for
rescue but supplies an intact ITR for gene conversion of de-
leted ITR-cell junctions (6, 29). Since these substrates can
resolve in the presence of host enzymes, this may be a common
mechanism for rescue of all latent AAV genomes. Our data
demonstrate rescue via resolution of DD ITR sequences and
support a model which has previously been proposed utilizing
DD ITR intermediates as critical components of AAV inte-
gration and rescue (25).
DD replication is efficient and not dependent on size. Our
replication assays demonstrated that this cis-acting substrate
was not dependent on plasmid size (Fig. 4B) and replicated
very efficiently compared to wild-type clones (Fig. 4A). The
effective replication and encapsidation of the DD construct
indicates the crucial role that the D sequence plays in these
processes. This is consistent with observations that deletion of
D sequences abolishes AAV replication and packaging (39, 40,
43). In addition, in vitro Rep68 binding and nicking assays are
affected by mutant substrates that altered the trs sequence or
FIG. 6. Genomic Southern analysis of the DD-neoAAV provirus structure in
latently infected Detroit 6 cell clones. Genomic DNA from various latent cells
was digested with restriction enzyme HindIII, a single cutter for vector se-
quences. DNA was fractionated on a 1% agarose gel and assayed for vector
sequences by Southern hybridization using a neo-specific probe. Lane M repre-
sents molecular weight markers; lanes 1 to 6 represent individual genomic clones.
The diagram illustrates the provirus structure as a linear molecule with ITRs
(hatched boxes) forming junctions with chromosome DNA (2//2). Ampicillin-
and G418-resistant genes of the plasmid vector are denoted by Amp and Neo,
respectively. ori is the pUC plasmid origin of replication (theta structure), and
the position of the HindIII restriction site is indicated. Sizes are indicated in
kilobases.
FIG. 7. Rescue assay of DD-neo proviruses. Latently DD-neo virus-infected
Detroit 6 cell clones were superinfected with wild-type AAV and Ad5. Low-
molecular-weight DNA was extracted and separated on 1% agarose gel. South-
ern blot hybridization was performed with 32P-labeled neo as a probe. M and D
represent the rescued and replicated provirus monomer and dimer molecules.
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spacing between A and D elements (23, 34). In our replication
assay, plasmid pDD-2 rescued and replicated much better
than infectious clones psub201 and at least as well as pSM620
(Fig. 4A). The difference in replication between psub201 and
pSM620 may be due to the respective ITR sequences. In
psub201, there is a terminal 13-bp deletion of both ITRs which
has been shown to impair rescue (28). In contrast, pSM620
contains two wild-type ITRs which were cloned by GC tailing.
The GC tails in this plasmid have been shown to be a substrate
for a cellular endonuclease (7). As a result, pSM620 may res-
cue more effectively through a cellular endonuclease that
cleaves the GC tail as well as resolution through the ITR
sequences. In spite of the two wild-type ITRs and GC tails in
pSM620, our data support just as efficient rescue and replica-
tion of pDD-2 (Fig. 4A). Since only one copy of the D element
is present in wild-type ITR clones, the potential to form the
extended D-A stem structure in pDD-2 is not possible for
plasmids pSM620 and psub201, suggesting that this may be the
most effective natural substrate for rescue and replication.
Moreover, the 13-bp deletion in the A region of psub201 fur-
ther prevents the ability to form this structure and most likely
is the reason for the inefficient rescue and consequently de-
layed replication of this substrate (28).
AAV replicating plasmids. Recently Yalkinoglu et al. have
shown that a plasmid named pA2Y1, containing 1 kb of the
extreme left half of AAV with a single ITR, could replicate in
cells treated with genotoxic reagents in a Rep-independent
manner (47). In our experiments, pDD-2 replication was com-
pletely dependent on Rep gene expression. In trying to explain
these observations, differences between constructs, such as the
modified ITR of pDD-2 compared to the single ITR with
additional AAV sequences (p5 and p19 promoters) of pA2Y1,
should not be overlooked (5, 8). In addition, the cellular en-
vironment for pDD-2 replication was AAV lytic, while pA2Y1
was assayed in cells treated with genotoxic reagents. Most
interestingly, the DD plasmids rescued and replicated as linear
molecules via the AAV replication scheme (12, 36), whereas
pA2Y1 replicated bidirectionally as a circular molecule (47).
Bidirectional replication of pA2Y1 is supportive of a carcino-
gen-inducible DNA amplification mechanism (47). Since both
assays utilized the ITRs as their origins, it will be interesting to
test if pDD-2 can also replicate as a circular molecule in cells
treated by genotoxic reagents.
The DD construct as a plasmid vector. One important char-
acteristic of wild-type AAV is its preferential integration into
human chromosome 19 (16–18, 30). Although targeted inte-
gration appears mediated by the ITRs in the presence of Rep
proteins (20, 25), this characteristic is apparently lost with
rAAV in the absence of Rep gene product (25, 38). Since the
DD ITR is functional in cis, reduces the TR requirement from
300 to 165 bp, and is cloned in a polylinker, this substrate
should facilitate further manipulation and mutational studies
aimed at understanding the role of the ITRs in replication,
packaging, and integration. In fact, preliminary studies with
this construct have supported this premise. For example, plas-
mids containing the DD ITR transfected in the presence of
Rep have been shown to preferentially integrate into chromo-
some 19 (42). This observation suggests that DD ITR plasmids
have potential as nonviral targeted vectors. The ability to cir-
cumvent the size limitation (5 kb) of AAV vectors and retain
targeted integration is of significant interest. Virus generated
from DD ITR plasmids was capable of integration and subse-
quent rescue, supporting the role of this sequence in all steps
of the AAV life cycle (Fig. 6 and 7). The inclusion of bacterial
origin and ampicillin-resistant sequences in these vectors has
facilitated the cloning and characterization of integrated pro-
viruses (48) compared to conventional genomic library meth-
ods (16, 30). Finally, as with the initial AAV infectious clone,
this study demonstrates the importance of AAV plasmid sub-
strates for dissecting the complex life cycle of this nonpatho-
genic defective parvovirus and suggests that these plasmid vec-
tors may be useful substrates for human gene therapy.
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